Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's Intraday Session

Author: Benzinga Insights | March 26, 2024 01:31pm

Gainers

  • Stoke Therapeutics (NASDAQ:STOK) stock moved upwards by 71.8% to $11.16 during Tuesday's regular session. The company's market cap stands at $498.5 million. The company's, Q4 earnings came out yesterday.
  • Mesoblast (NASDAQ:MESO) stock moved upwards by 64.95% to $3.63. The market value of their outstanding shares is at $368.2 million.
  • OpGen (NASDAQ:OPGN) shares increased by 42.1% to $0.68. The company's market cap stands at $6.7 million.
  • Alpha Teknova (NASDAQ:TKNO) shares rose 36.92% to $3.3. The market value of their outstanding shares is at $134.6 million.
  • Nuvation Bio (NYSE:NUVB) shares moved upwards by 32.22% to $2.98. The company's market cap stands at $651.6 million.
  • Journey Medical (NASDAQ:DERM) stock moved upwards by 28.42% to $3.75. The company's market cap stands at $72.4 million. As per the press release, Q4 earnings came out 3 days ago.

Losers

  • NeuBase Therapeutics (NASDAQ:NBSE) stock declined by 51.8% to $0.48 during Tuesday's regular session. The company's market cap stands at $1.7 million.
  • Prenetics Global (NASDAQ:PRE) shares decreased by 18.23% to $3.68. The company's market cap stands at $44.9 million.
  • Equillium (NASDAQ:EQ) stock decreased by 18.04% to $2.0. The market value of their outstanding shares is at $70.2 million. As per the news, the Q4 earnings report came out yesterday.
  • SCWorx (NASDAQ:WORX) shares fell 17.11% to $2.81. The company's market cap stands at $3.4 million.
  • Monte Rosa Therapeutics (NASDAQ:GLUE) stock decreased by 17.03% to $7.02. The company's market cap stands at $352.0 million.
  • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares decreased by 15.37% to $0.83. The company's market cap stands at $3.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BDRX DERM EQ GLUE MESO NBSE NUVB OPGN PRE STOK TKNO WORX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist